Pfizer Inc. Broadens Lipitor Recall Over ‘Uncharacteristic’ Odor
December 23rd, 2010 - 8:27 pm ICT by GDBy Gina Gomez
Dec 23, (THAINDIAN NEWS) Cholesterol drug Lipitor received another setback earlier this week when more bottles of the drug was recalled by Pfizer Inc. after a number of consumers complained that they had found a foul smell. The new recall brings under its purview an additional 19,000 bottles of 40 mg of Lipitor pills, which takes the total number of bottles of the cholesterol drug affected by the recall to 360,000. The extension in the recall that was announced on Tuesday marks the fourth such recall affecting the drug this year.
A statement that has been released the drug developer Pfizer Inc. hinted that the main reason for the characteristic odor found in the bottles of Lipitor is attributed to a chemical known as 2,4,6-tribromoanisole (TBA), which imparts the musty odor to the bottles containing the cholesterol drug. The same chemical which is often used as a wood preservative, was responsible for triggering the recall of Lipitor earlier on. The statement issued by the drug developer further goes on to say that the company always binds to ‘rigorous quality and compliance program’ which takes into account sensitive surveillance system, a fact that has made it possible for Pfizer to detect and respond to the issue.
Despite the fact that owing to the successive recalls, as many as 360,000 bottles of Lipitor are off the market, the manufacturing company has emphasized that it would in no way result in shortage of the cholesterol drug. The recall of the product first came into the picture in the month of August, however, any official announcement the Pfizer Inc. was not made until October when the recall was extended.
- Cholesterol Drug Lipitor Recalled By Pfizer Inc. For The Third Time - Oct 31, 2010
- J&J recalls epilepsy drug - Apr 14, 2011
- FDA rejects combo cholesterol drug - Mar 07, 2012
- Tylenol Arthritis Pain Caplet is being recalled - Jan 03, 2010
- Ranbaxy approved to make first generic version of Lipitor - Dec 01, 2011
- Johnson & Johnson Expands Recall Of Tylenol, Benadryl And Motrin - Jul 09, 2010
- Tylenol Recalled By Johnson & Johnson Again - Oct 20, 2010
- Johnson & Johnson: Tylenol recall expanded - Jul 09, 2010
- Ranbaxy ordered to improve India, US plants - Jan 26, 2012
- FDA orders lowering of pain relieving ingredient in Vicodin - Jan 14, 2011
- TCG Lifesciences to foray into bio-tech medicine - Feb 16, 2012
- Argentine government takes over train operator after crash - Feb 29, 2012
- Odor coding in mammals much more complex than previously thought - Oct 26, 2010
- Kellogg's Cereal Recall Explained By The Company - Jun 29, 2010
- Pfizer offers free prescription drugs to people who have lost their jobs - May 15, 2009
Tags: characteristic odor, cholesterol, cholesterol drug, compliance program, drug developer, foul smell, gina gomez, lipitor, manufacturing company, month of august, musty odor, pfizer, pfizer inc, pills, purview, rigorous quality, setback, surveillance system, tba, wood preservative